Popular Articles
Teeth Whitening

WHO And EFA Call For Global Action On Chronic Respiratory Disease
The World Health Organisation (WHO) and European Federation of Allergy and Airways Diseases (EFA) today announced that they are bringing together over 150 international delegates to discuss the growing epidemic of Chronic Respiratory Diseases (CRD) that affects one billion people worldwide1, [2], [3] and is responsible for four million deaths annually1. The conference which will discuss the implementation of a five-year initiative to unite policy makers, providers and patient groups will be hosted by the Italian Ministry of Health in Rome on June 12 and 13.
generic viagra online
Study Rewrites Textbook On Key Genetic Phenomenon
Because females carry two copies of the X chromosome to males" one X and one Y, they harbor a potentially toxic double dose of the over 1000 genes that reside on the X chromosome.
plastic surgery before after
News of the day
What The Immune System Reveals About Breast Cancer
Researchers working with Dr Marcus Schmidt in the Department of Obstetrics and Gynecology at the University Medical Center Mainz have unlocked the key to the immune system"s significance in cases of breast cancer, thus identifying its long-neglected role in the prognosis of the disease. Their research results, published in the renowned Cancer Research journal, show that patients with certain breast tumors have a better prognosis when more immune cells are present in the tumor. These results permitted the scientists to extend the "coordinate system" in case of breast tumors to include the immune system as the third important reference point for the prognosis of this disease, in addition to the long-established prognostic factors of estrogen receptor expression and proliferative activity (Cancer Research, 1 July 2008; Cancer Research, 1 April 2009).
Public Health

New Noninvasive Technique Monitors Fetal Heartbeat

Tiny fluctuations in a fetus"s heartbeat can indicate distress, but currently there is no way to detect such subtle variations except during labor, when it could be too late to prevent serious or even fatal complications. Now, a new system developed by an MIT scientist and colleagues including an obstetrician could allow much earlier monitoring of the fetal heartbeat. The additional researchers are from the Institut National Polytechnique de Grenoble, Sharif University, Tufts Medical Center, and E-TROLZ Inc. Among other advantages, the system is expected to be less expensive and easier to use than current technologies. It could also cut the rate of Cesarean deliveries by helping clinicians rule out potential problems that might otherwise prompt the procedure. Finally, the device used today to monitor subtle changes in the fetal heartbeat during labor must be attached to the fetus itself, but the new product would be noninvasive. "Our objective is to make a monitoring system that"s simultaneously cheaper and more effective" than what is currently available, said Gari Clifford, PhD, a principal research scientist at the Harvard-MIT Division of Health Sciences and Technology. Clifford expects that the system could be commercially available in two to three years pending FDA approval. While only a minority of pregnancies suffer from fluctuations in the fetal heartbeat, the issue is nonetheless critical because those that do can result in bad outcomes. These problems include certain infections and a loss of oxygen to the baby if it is strangled by its own umbilical cord. Two techniques Doctors today actually have two ways to detect the fetal heartbeat. Ultrasound, in which a doctor moves a device that looks roughly like a hockey puck over a woman"s abdomen or she wears a belt fitted with sensors, can detect the heartbeat quite early in a pregnancy. However, it is not sensitive enough to catch variations in the rhythm that could indicate problems. Electrocardiography (better known as ECG or EKG), which records the electrical activity of the heart, can indeed catch subtle changes in the fetal heartbeat. The problem: until now there has been no way to reliably use the technique to that end except by attaching an electrode to the baby"s scalp during labor. Doctors can monitor the fetal ECG signal noninvasively through electrodes on the mother"s abdomen, but it is weak compared to the maternal heartbeat and surrounding noise. Further, it has not been possible to separate the three signals without distorting characteristics of the fetal heartbeat key to identifying potential clinical problems. "The dominant signal turns out to be the mother"s heartbeat, so teasing out a tiny fetal signal in the background noise without altering the clinical meaning of the fetal signal is a problem that has proved virtually insoluble," said Clifford. The new system separates the maternal ECG signal from the fetus"s and background noise thanks to a complex algorithm derived from the fields of signal processing and separation. Together, these fields work to break any signal into its components. Clifford"s principal colleagues on the signal-processing work include Dr. Reza Sameni (whose PhD work focused on this problem), Professor Christian Jutten of Institut National Polytechnique de Grenoble, and Professor Mohammad B. Shamsollahi of Sharif University. The researchers have described their approach in papers published in journals including the IEEE Transactions on Biomedical Engineering and the EURASIP Journal on Advances in Signal Processing. To use the system, which the team believes could be deployed during the second trimester of pregnancy (around 20 weeks) and perhaps earlier, a woman would wear a wide belt around her abdomen fitted with several ECG electrodes. (The prototype has 32, but that number will be lower in the final device.) The data collected from those electrodes are then fed to a monitor and analyzed with the new algorithm, which in turn separates the different signals. Multidimensional View Clifford notes that "one of the nice things about monitoring the fetal ECG through the mother"s abdomen is you"re getting a multidimensional view of the fetal heart" because its electrical activity is recorded from many different angles. The single probe now used to monitor the heartbeat during labor gives data from only one direction. "So with our system it"s like going from a one-dimensional slice of an image to a hologram," Clifford said. That better view could help catch problems that might have gone unnoticed before. "If you"re looking in just one direction and an abnormality is occurring perpendicular to that direction, you won"t see it," Clifford said. The large amounts of 3-D data captured with the new system could also open up a new field of research: fetal electrocardiography. "The world of fetal ECG analysis is almost completely unexplored," Clifford said, because the current monitoring system can only be used during labor and "essentially gives only a monocular view." Clifford"s key collaborator on the clinical work is Dr. Adam Wolfberg, an obstetrician and a fellow in maternal fetal medicine at Tufts Medical Center. To validate the algorithm and build the system, he turned to E-TROLZ. Recently, several patent applications on the work were licensed by MindChild Medical Inc. The original development of the device was funded by the Center for Integration of Medicine and Innovative Technology (CIMIT). Elizabeth Thomson Massachusetts Institute of Technology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):